In a phase 2 study in people with obesity (without T2D), retatrutide (doses 1 to 12 mg) has led to a dose-dependent WL up to 24.2% at the end of the 48-week treatment period compared to 2.1% with placebo [81]
We do not offer compounded versions
Many patients start therapy motivated, but early side effects can quickly discourage continued use
Li, J., Sun, W., Zhu, X., Mei, Y., Li, W., & Li, J
Malabsorption from coeliac disease, Crohns, gastric surgery or long-term metformin and proton-pump inhibitors accounts for much of the rest
Using Wrong Syringe Conversions Many beginners confuse: insulin syringe units Milliliters milligrams Adding Incorrect BAC Water Amount Changing dilution volume changes the entire concentration